Voglibose tablets 0.3 mg for postprandial hyperglycemia (Voglib, Volix)

General information on Japanese Voglibose tablets 0.3 mg from Japan for postprandial hyperglycemia (Voglib, Volix)

Package details: 100 tablets

Manufacturer: Sawai Pharmaceutical Co. Ltd., Japan

Active ingredient: voglibose (chemical formula C10H21NO7)

Medical effect: Voglibose tablets are effective for decreasing reactive (post-meal) hyperglycemia.

Contraindications and precautions: do not use for the following categories of patients:

• pregnant and breastfeeding women,
• patients with ketosis, diabetic coma or precoma,
• patients with infections or external injury,
• patients in the pre-/post-operative period.

Strictly follow your doctor’s instructions on dietary and exercise therapy. If you feel the symptoms of hypoglycemia (cold and sweating, arms and legs trembling etc.), take glucose. As the decreased blood sugar may cause dizziness, avoid driving a car or operating dangerous mechanisms while taking this medicine.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

Dosage and administration of Voglibose tablets 0.3 mg from Japan for postprandial hyperglycemia (Voglib, Volix)

For adults, start with 0.2 mg of the active ingredient at a time, three times a day immediately before each meal. If its effect is insufficient, the dosage may be increased up to 0.3 mg at a time. Please note that this medicine contains 0.3 mg of the active ingredient in a tablet.

Voglibose tablets can be taken without water. You can moisten the tablet with saliva on your tongue, then crush it lightly with your tongue, and swallow the tablet with saliva.

How effective are Voglibose tablets 0.3 mg from Japan for postprandial hyperglycemia (Voglib, Volix)?

Voglibose is an alpha-glucosidase inhibitor. It works by suppressing the actions of digestive enzymes that degrade carbohydrate and, by this delaying digestion and absorption of carbohydrate. Voglibose tablets effectively suppress rapid increases in blood glucose levels after meals.

Who should take Voglibose tablets 0.3 mg from Japan?

Voglibose tablets can be used for preventing after-meal glucose increase in patients with non-insulin dependent diabetes mellitus, insulin-dependent patients and patients with steroid-induced diabetes and non-diabetic hyperinsulinaemia. These tablets are generally well-tolerated and safe. Studies also showed that voglibose helps to prevent diabetes in high risk group patients with impaired glucose tolerance and to reduce risk of microvascular and neuropathic complications of diabetes (A. S. Dabhi, N. R. Bhatt, M. J. Shah. “Voglibose: An Alpha Glucosidase Inhibitor”. Journal of Clinical and Diagnostic Research. 2013, December, 7(12): 3023-3027).